147 related articles for article (PubMed ID: 15166203)
1. Commentary: hazards of studying women: the oestrogen oestrogen/progesterone dilemma.
Kuller LH
Int J Epidemiol; 2004 Jun; 33(3):459-60. PubMed ID: 15166203
[No Abstract] [Full Text] [Related]
2. Commentary: observation versus intervention--what's different?
Barrett-Connor E
Int J Epidemiol; 2004 Jun; 33(3):457-9. PubMed ID: 15166202
[No Abstract] [Full Text] [Related]
3. Commentary: hormone replacement therapy and coronary heart disease: four lessons.
Petitti D
Int J Epidemiol; 2004 Jun; 33(3):461-3. PubMed ID: 15166191
[No Abstract] [Full Text] [Related]
4. Commentary: the hormone replacement-coronary heart disease conundrum: is this the death of observational epidemiology?
Lawlor DA; Davey Smith G; Ebrahim S
Int J Epidemiol; 2004 Jun; 33(3):464-7. PubMed ID: 15166201
[No Abstract] [Full Text] [Related]
5. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
von Schoultz B
Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
[No Abstract] [Full Text] [Related]
6. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormones and risk of ovarian cancer.
Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
[TBL] [Abstract][Full Text] [Related]
8. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
[TBL] [Abstract][Full Text] [Related]
9. Commentary: hormones and heart disease: do trials and observational studies address different questions?
Stampfer M
Int J Epidemiol; 2004 Jun; 33(3):454-5. PubMed ID: 15166192
[No Abstract] [Full Text] [Related]
10. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
11. [Difficult decisions on estrogen treatment of women with coronary diseases].
al-Khalili F
Lakartidningen; 1999 May; 96(18):2196. PubMed ID: 10377656
[No Abstract] [Full Text] [Related]
12. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
Mohandas B; Mehta JL
Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone therapy and venous thromboembolism.
Olié V; Canonico M; Scarabin PY
Thromb Res; 2011 Feb; 127 Suppl 3():S26-9. PubMed ID: 21262434
[TBL] [Abstract][Full Text] [Related]
14. Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.
Genazzani A; Gambacciani M; Simoncini T; Anniverno R; Becorpi AM; Biglia N; Brandi ML; Guaschino S; Lello S; Massobrio M; Melis GB; Mencacci C; Modena MG; Nappi C; Nappi RE; Pecorelli S; Petraglia F; Rosano GM; Serra GB; Sismondi P; Taddei S; Tonelli F
Gynecol Endocrinol; 2007; 23(8):436-44. PubMed ID: 17934930
[No Abstract] [Full Text] [Related]
15. Is there a link between oestrogen therapy and gallbladder disease?
Dhiman RK; Chawla YK
Expert Opin Drug Saf; 2006 Jan; 5(1):117-29. PubMed ID: 16370961
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progestogen therapy in postmenopausal women.
Practice Committee of American Society for Reproductive Medicine
Fertil Steril; 2008 Nov; 90(5 Suppl):S88-102. PubMed ID: 19007655
[TBL] [Abstract][Full Text] [Related]
18. Progesterone, progestins, pregnancy and breast cancer risk.
Ferretti G
Breast Cancer Res Treat; 2007 Jul; 103(3):373-4. PubMed ID: 17063269
[No Abstract] [Full Text] [Related]
19. The effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides.
Renehan AG; Frystyk J; Howell A; O'dwyer ST; Shalet SM; Flyvbjerg A
Growth Horm IGF Res; 2007 Jun; 17(3):210-9. PubMed ID: 17360217
[TBL] [Abstract][Full Text] [Related]
20. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement.
Kalantaridou SN; Naka KK; Bechlioulis A; Makrigiannakis A; Michalis L; Chrousos GP
Trends Endocrinol Metab; 2006 Apr; 17(3):101-9. PubMed ID: 16515863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
